Search results
Novartis AG (NYSE:NVS) Shares Sold by Park National Corp OH
ETF DAILY NEWS· 2 days agoPark National Corp OH trimmed its position in shares of Novartis AG (NYSE:NVS – Free Report) by 10.5% in the first quarter, according to its most recent filing with the Securities ...
Here's Why Novartis (NVS) is a Strong Momentum Stock
Zacks via Yahoo Finance· 1 day agoThis investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week...
Wellington Management Group LLP Buys 54,683 Shares of Novartis AG (NYSE:NVS)
ETF DAILY NEWS· 4 days agoWellington Management Group LLP increased its stake in shares of Novartis AG (NYSE:NVS – Free Report) by 1.2% in the 4th quarter, according to its most recent 13F filing with ...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 5 hours agoAmyloid plaque and P-tau are key biomarkers of Alzheimer's disease and their reduction is likely to...
Tectonic bets on GPCR heart failure drug following reverse merger with Avrobio
Pharmaceutical Technology via Yahoo Finance· 2 hours agoThe merged company’s stock debuted at a share price of $16.80 on the Nasdaq. The companies first...
Top 5 Small-Cap Biotechnology Stocks for a Stable Portfolio
Zacks via Yahoo Finance· 5 hours agoFurther, BCYC collaborates with biopharmaceutical companies and organizations to develop programs in...
Behind the Scenes of Intellia Therapeutics's Latest Options Trends - Intellia Therapeutics...
Benzinga· 21 hours agoPresent Market Standing of Intellia Therapeutics Trading volume stands at 742,147, with NTLA's price down by -0.65%, positioned at $24.64. RSI indicators show the
Ionis (IONS) Expands Licensing Deal With Otsuka for HAE Drug
Zacks via Yahoo Finance· 2 days agoIonis (IONS) out-licenses the rights for its HAE drug to Otsuka in the Asia-Pacific region. The...
Street calls of the week: Upgrade for Shopify; downgrades for AMD, Paramount
Investing.com via Yahoo Finance· 6 days agoParamount Global opened the regular session at $10.71 and closed... ADR (NASDAQ:MREO) at Outperform with a $8 price target What’s the full story? Baird observes that Mereo ...